Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet

被引:12
|
作者
Zhao, Jingyu [1 ]
Bai, Meijuan [1 ]
Wei, Siying [1 ]
Li, Chenchen [2 ]
Lv, Qi [3 ]
Chen, Yan [1 ,2 ]
机构
[1] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai 200031, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[3] Tongji Univ, Sch Med, Tongji Hosp, Dept Med Imaging, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金;
关键词
dietary restriction; fatty acid oxidation; fatty liver disease; lipolysis; obesity; REGENERATION;
D O I
10.1002/mnfr.202100381
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Scope Liver plays a central role in maintaining lipid homeostasis which is dysregulated in non-alcoholic fatty liver disease (NAFLD) caused by overload of dietary fat, increase in lipid synthesis, and alteration of fatty acid oxidation in the liver. In this study, we aimed to investigate whether intermittent calorie restriction using a fasting-mimicking diet (FMD) is able to slow down the progression of NAFLD in mice. Methods and Results This study analyzed the intervention activity of a FMD low in carbohydrate/protein but high in dietary fibers with a NAFLD mouse model induced by high-fat high-sucrose diet (HFHSD). Intermittent application of the FMD reduces HFHSD-induced obesity and glucose intolerance. The FMD decreases the size of adipocytes and elevates expression of lipolysis genes and HSL protein in white adipose tissue. HFHSD-induced lipid accumulation in the liver is reduced by the FMD, accompanied by a reduction of macrophage marker in the liver. RNA sequencing reveals that the expression of a number of genes involved in fatty acid oxidation is elevated by the FMD. Conclusion The findings indicate that intermittent application of the FMD can improve NAFLD, at least in part, through increased lipolysis in white adipose tissue and elevated fatty acid oxidation in the liver.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease: Improvement in liver histology with weight loss
    Dixon, JB
    Bhathal, PS
    Hughes, NR
    O'Brien, PE
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S180 - S180
  • [42] Intermittent administration of a fasting-mimicking diet reduces intestinal inflammation and promotes repair to ameliorate inflammatory bowel disease in mice
    Song, Shuo
    Bai, Meijuan
    Ling, Zhiqiang
    Lin, Yijun
    Wang, Shuo
    Chen, Yan
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2021, 96
  • [43] Role of diet and nutritional management in non-alcoholic fatty liver disease
    Fan, Jian-Gao
    Cao, Hai-Xia
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 81 - 87
  • [44] Nutritional status, diet and non-alcoholic fatty liver disease in elders
    de Melo Portela, Clarissa Lima
    de Carvalho Sampaio, Helena Alves
    Pereira de Melo, Maria Luisa
    Ferreira Carioca, Antonio Augusto
    Maia Pinto, Francisco Jose
    Machado Arruda, Soraia Pinheiro
    NUTRICION HOSPITALARIA, 2015, 32 (05) : 2038 - 2045
  • [45] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [46] Assessment of intestinal barrier function in mice with non-alcoholic fatty liver disease subjected to intermittent hypoxia
    Cruz, Rodrigo
    Cabrera, Daniel
    Solis, Nancy
    Cofre, Catalina
    Hernandez, Alejandra A.
    Barrera, Francisco
    Arrese, Marco
    HEPATOLOGY, 2017, 66 : 1076A - 1076A
  • [47] Molecular pathways involved in the improvement of non-alcoholic fatty liver disease
    Paz-Filho, Gilberto
    Mastronardi, Claudio Alberto
    Parker, Brian J.
    Khan, Ainy
    Inserra, Antonio
    Matthaei, Klaus I.
    Ehrhart-Bornstein, Monika
    Bornstein, Stefan
    Wong, Ma-Li
    Licinio, Julio
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 51 (01) : 167 - 179
  • [48] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [49] Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease
    Ji, Yang
    Liang, Yingmin
    Mak, Judith C. W.
    Ip, Mary S. M.
    SLEEP MEDICINE, 2022, 95 : 16 - 28
  • [50] The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry
    Alorfi, Nasser M.
    Ashour, Ahmed M.
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 3115 - 3121